| |
|
|
|
|
|
|
|||
|
RED CELLS
From the Department of Haematology-Oncology and
University of Adelaide Department of Medicine, Queen Elizabeth
Hospital, Australia.
Loss of A, B, and H antigens from the surface of red blood cells
has been a recurrent observation in patients with hematologic malignancy, particularly those malignancies in which the myeloid lineage is involved. To better understand this phenomenon, a 2-color flow cytometric method was developed to determine quantitative and
qualitative alterations of A, B, and H antigens in patients with
myeloid malignancies. Characteristic patterns, dependent on the
genotype, were seen for healthy individuals from each of the blood
groups. Fifty-five percent (16/29) of patients of blood group A, B, or
AB had a proportion of red cells with decreased expression of A or B
antigens compared with no changes in 127 healthy A, B, and AB
individuals. In most cases, the changes were not detected by routine
serologic typing. The loss of A or B antigens was the primary change in
28% (8/29) of patients. In 17% (5/29) of patients, loss of A or B
antigens was an indirect consequence of loss of the precursor H
antigen. Alterations involving both the H and the A or B antigens were
seen in 10% (3/29) of patients. Loss of H was also detected in 21%
(6/28) of group O patients whereas none of 51 healthy O individuals
showed changes. Alterations of ABO antigens can now be considered a
common event in myeloid malignancy. This article has been cited by other articles:
| ||||||||||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||